# Heart Lung Machine Market

> Heart Lung Machine Market Research Report: Size, Share, Trend Analysis By Product Type (Cardiopulmonary Bypass Machine, Extracorporeal Membrane Oxygenation (ECMO) Machine, Assist Devices), By Applicationss (Heart Surgery, Lung Surgery, Cardiac Arrest, Respiratory Failure), By Patient Age (Neonates, Children, Adults), By Flow Rate (Low Flow (less than 1 L/min), Medium Flow (1-2 L/min), High Flow (greater than 2 L/min), By Number of Circuits (Single-Circuit Machines, Dual-Circuit Machines, Multi-Circuit Machines) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.49%
- **2024:** $ 8.86 Billion
- **2025:** $ 9.26 Billion
- **2035:** $ 14.36 Billion
- **Key Players:** Medtronic(US), Terumo Corporation (JP), Getinge AB (SE), LivaNova PLC (GB), Abbott Laboratories (US), Cardinal Health (US), Sorin Group (IT), Nipro Corporation (JP), Fresenius SE & Co. KGaA (DE)

**Report ID:** MRFR/HC/39042-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/heart-lung-machine-market-41089

---

## Market Summary

## **Heart Lung Machine Market Overview**

Heart Lung Machine Market Size was estimated at 8.11 (USD Billion) in 2022. The Heart Lung Machine Market Industry is expected to grow from 8.48(USD Billion) in 2023 to 12.58 (USD Billion) by 2032. The Heart Lung Machine Market CAGR (growth rate) is expected to be around 4.49% during the forecast period (2024 - 2032).

### **Key Heart Lung Machine Market Trends Highlighted**

The Heart-Lung Machine Market is primarily driven by increasing instances of heart and lung diseases, advancement and innovation in device technology geared towards ECMO, and growing popularity and practices of minimally invasive cardiac surgical techniques. Another factor that is aiding the growth of this market is the increasing elderly population and penetration of advanced healthcare facilities in developing nations.

Other untapped opportunities in the market include the introduction of portable and single-use heart-lung machines and the addition of AI and machine learning for better performance and results. ECMO devices are expected to grow in applications such as VA ECMO, where heart-lung machines are no longer limited to cardiac surgery equipment but are instead also used to support patients who have lost the function of the lungs.

Modern advances such as heart-lung machines are said to be in tune with the adoption of disposables, oxygenators, and consumables with the aim of reducing infection rates and improving cost-effectiveness. The increase in the number of robotic heart surgical procedures is also influencing the design of heart-lung machines to be more accurate when performing minimally invasive cardiac surgery techniques.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Heart Lung Machine Market Drivers**

### **Increasing Prevalence of Cardiovascular Diseases**

Cardiovascular diseases (CVDs) are a leading cause of death worldwide, and their prevalence is on the rise. According to the World Health Organization (WHO), CVDs accounted for an estimated 17.9 million deaths in 2019, representing 32% of all deaths. The increasing prevalence of CVDs is a major driver of the growth of the Heart Lung Machine Market Industry, as these devices are essential for the treatment of a variety of cardiovascular conditions, including coronary artery disease, valvular heart disease, and congenital heart defects. 

The rising incidence of CVDs can be attributed to a number of factors, including population aging, unhealthy lifestyles, and the increasing prevalence of obesity and diabetes. As the population ages, the number of people with CVDs is expected to increase significantly. Additionally, the adoption of unhealthy lifestyles, such as smoking, excessive alcohol consumption, and lack of physical activity, is contributing to the rise in CVDs.

Obesity and diabetes are also major risk factors for CVDs, and their prevalence is increasing worldwide. The increasing prevalence of CVDs is creating a significant need for heart-lung machines, which are used to provide temporary circulatory and respiratory support during cardiac surgery and other procedures. As the number of CVD patients increases, the demand for heart-lung machines is also expected to grow.

### **Technological Advancements**

Technological advancements are also driving the Heart Lung Machine Market Industry. Recent years have seen the development of a number of new and innovative heart lung machines that offer improved performance and safety. These advancements include the development of new materials, such as biocompatible polymers, which are used to make heart-lung machine components more durable and less likely to cause blood clotting.

Additionally, the development of new control systems has improved the accuracy and reliability of heart-lung machines.Technological advancements are also leading to the development of new applications for heart-lung machines. For example, heart-lung machines are now being used to support patients during minimally invasive cardiac surgery, which is a less invasive and more effective alternative to traditional open-heart surgery.

Additionally, heart-lung machines are being used to support patients with severe respiratory failure, such as those with acute respiratory distress syndrome (ARDS).As technology continues to advance, heart-lung machines are expected to become even more versatile and effective, which will further drive the growth of the Heart Lung Machine Market Industry.

### **Rising Demand for Minimally Invasive Cardiac Surgery**

Minimally invasive cardiac surgery (MICS) is a surgical technique that uses small incisions and specialized instruments to perform heart surgery. MICS is less invasive than traditional open-heart surgery, which requires a large incision in the chest. As a result, MICS is associated with less pain, scarring, and recovery time.

The rising demand for MICS is a major driver of the growth of the Heart Lung Machine Market Industry, as heart-lung machines are essential for the performance of MICS procedures. The increasing popularity of MICS can be attributed to a number of factors, including the aging population, the increasing prevalence of CVDs, and the rising demand for less invasive surgical procedures.

As the population ages, the number of people with CVDs is expected to increase significantly. Additionally, the increasing prevalence of obesity and diabetes is also contributing to the rise in CVDs. These factors are leading to a greater demand for cardiac surgery, and MICS is becoming the preferred surgical approach for many patients.

## **Heart Lung Machine Market Segment Insights**

### **Heart Lung Machine Market Product Type Insights  **

Heart Lung Machine Market is segmented by product type into [Cardiopulmonary Bypass Machines](../../../reports/cardiopulmonary-bypass-equipment-devices-market-16221), Extracorporeal Membrane Oxygenation (ECMO) Machines, and Assist Devices. The Cardiopulmonary Bypass Machine segment held the largest market share in 2023, accounting for over 55% of the revenue. This dominance is attributed to the widespread use of cardiopulmonary bypass procedures in cardiac surgeries, such as coronary artery bypass grafting and valve replacement.

The Extracorporeal Membrane Oxygenation (ECMO) Machine segment is expected to witness significant growth over the forecast period, driven by the increasing prevalence of respiratory failure and the growing adoption of ECMO as a life-saving intervention.

The Assist Devices segment includes ventricular assist devices (VADs) and total artificial hearts (TAHs), which are used to support or replace the function of a failing heart. The increasing prevalence of cardiovascular diseases, the rising demand for minimally invasive surgical procedures, and the technological advancements in heart-lung machines are key factors driving the market growth.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Heart Lung Machine Market Applications Insights  **

The Heart Lung Machine Market is segmented by Applications, which include Heart Surgery, Lung Surgery, Cardiac Arrest, and Respiratory Failure. The Heart Surgery segment held the largest market share in 2023 and is expected to continue its dominance throughout the forecast period.

The increasing prevalence of cardiovascular diseases and the growing number of heart surgeries are key factors driving the growth of this segment. The Lung Surgery segment is also expected to witness significant growth over the forecast period due to the rising incidence of lung cancer and other respiratory diseases.The Cardiac Arrest and Respiratory Failure segments are expected to grow at a steady pace due to the increasing awareness about these conditions and the availability of advanced treatment options.

### **Heart Lung Machine Market Patient Age Insights  **

The Patient Age segment plays a crucial role in shaping the dynamics of the Heart Lung Machine Market. Neonates, children, and adults constitute the primary patient age groups in this market. Neonates, defined as infants less than 28 days old, represent a significant market segment due to the high incidence of congenital heart defects and the need for specialized heart-lung machines tailored to their unique physiological requirements.

Children, ranging in age from 28 days to 18 years, also contribute substantially to the market, as they may require heart-lung support during complex cardiac surgeries or interventions.Adults, including individuals over 18 years of age, represent the largest patient age segment in the Heart Lung Machine Market. The growing prevalence of cardiovascular diseases, such as coronary artery disease and heart failure, among the aging population is a key driver for market growth in this segment.

### **Heart Lung Machine Market Flow Rate Insights  **

The Heart Lung Machine Market is segmented by flow rate into low flow (less than 1 L/min), medium flow (1-2 L/min), and high flow (greater than 2 L/min). The high-flow segment is expected to hold the largest market share in 2023, owing to the increasing prevalence of complex cardiac surgeries that require high flow rates to maintain adequate organ perfusion.

The low-flow segment is expected to witness a steady growth rate over the forecast period, driven by the growing adoption of minimally invasive cardiac surgeries. The medium flow segment is expected to account for a significant share of the market due to its versatility and applicability in a wide range of cardiac procedures.The market growth is attributed to the rising incidence of cardiovascular diseases, technological advancements in heart-lung machines, and increasing healthcare expenditure in emerging economies.

### **Heart Lung Machine Market Number of Circuits Insights  **

The Heart Lung Machine Market is segmented based on the Number of Circuits into Single-Circuit Machines, Dual-Circuit Machines, and Multi-Circuit Machines. In 2023, the Single-Circuit Machines segment held the largest market share of around 55%. The growth of this segment can be attributed to the increasing adoption of minimally invasive cardiac surgeries, which require smaller and more portable heart-lung machines.

The Dual-Circuit Machines segment is expected to witness a significant growth rate during the forecast period, owing to the rising prevalence of complex cardiac surgeries that require multiple circuits to provide adequate blood flow and oxygenation.The Multi-Circuit Machines segment is expected to account for a smaller market share due to its limited applications in specific surgical procedures.

### **Heart Lung Machine Market Regional Insights  **

The Heart Lung Machine Market is segmented into North America, Europe, APAC, South America, and MEA. The North American region is expected to hold the largest market share, followed by Europe and APAC. The growth in the North American region is attributed to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive surgeries. The European market is expected to grow at a steady pace, driven by the increasing adoption of advanced technologies and the growing number of cardiac surgeries.

The APAC region is expected to witness the fastest growth, owing to the rising healthcare expenditure and the increasing awareness about heart-lung machines.The South American and MEA regions are expected to grow at a moderate pace, driven by the increasing number of hospitals and the growing demand for cardiac care. North America 3.378 - 4.753 USD Billion, Europe 2.099 - 3.176 USD Billion, South America 0.651 - 0.98 USD Billion, Asia-Pacific 1.953 - 3.059 USD Billion, Middle East and Africa 0.398 - 0.612 USD Billion.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Heart Lung Machine Market Key Players and Competitive Insights**

Major players in the Heart Lung Machine Market are constantly competing to gain an edge in the industry. Leading Heart Lung Machine Market players are focusing on developing innovative products and technologies, expanding their reach, and strengthening their distribution channels. Key players are adopting various strategies, such as mergers and acquisitions, joint ventures, and strategic partnerships, to enhance their market position.

In addition, new entrants and emerging markets are challenging the existing competitive landscape and driving Heart Lung Machine Market development.Stryker Corporation is a leading player in the Heart Lung Machine Market and offers a wide range of advanced products and solutions. The company is renowned for its commitment to innovation and customer satisfaction. With a strong presence and a comprehensive distribution network, Stryker Corporation effectively serves healthcare facilities worldwide.

Its continuous focus on product development, strategic acquisitions, and long-standing customer relationships contribute to its leading position in the Heart Lung Machine Market industry.Medtronic, a prominent competitor in the Heart Lung Machine Market, is recognized for its innovative technologies and comprehensive product portfolio.

The company holds a strong position in the market and has established a robust presence in key regions. Medtronic emphasizes research and development, investing in advanced technologies and solutions to meet the evolving needs of healthcare professionals and patients. Through its strong brand reputation, distribution network, and strategic partnerships, Medtronic remains a formidable competitor in the Heart Lung Machine Market Competitive Landscape.

### **Key Companies in the Heart Lung Machine Market Include**

- Roche Diagnostics
- LivaNova PLC
- BD
- Siemens Healthineers
- Abbott
- **[Stryker](https://www.stryker.com/us/en/portfolios/medical-surgical-equipment.html)**
- Terumo Cardiovascular Systems
- Medtronic
- Fresenius SE KGa 
- HemoCue AB
- Natus Medical Incorporated
- Maquet
- Zoll Medical Corporation
- Sorin Group
- Getinge AB

## **Heart Lung Machine Market Industry Developments**

The heart-lung machine market is projected to grow from an estimated USD 8.48 billion in 2024 to USD 12.58 billion by 2032, at a CAGR of 4.49%. This growth is attributed to the increasing prevalence of cardiovascular diseases, the rising demand for minimally invasive surgeries, and technological advancements in heart-lung machines.Key recent developments in the market include In 2023, Medtronic received FDA approval for its HeartWare HVAD System, the first implantable heart pump designed for patients with advanced heart failure who are not eligible for heart transplantation.

 In 2024, Abbott launched the CentriMag Blood Pump System, a next-generation heart-lung machine that offers improved patient outcomes and reduced complications. In 2025, Terumo Cardiovascular Group announced the acquisition of Vascutek, a leading provider of cardiovascular devices, including heart-lung machines.These developments indicate a growing focus on innovation and patient-centric solutions in the heart-lung machine market.

## **Heart Lung Machine Market Segmentation Insights**

### **Heart Lung Machine Market Product Type Outlook**

- Cardiopulmonary Bypass Machine
- Extracorporeal Membrane Oxygenation (ECMO) Machine
- Assist Devices

### **Heart Lung Machine Market Applications Outlook**

- Heart Surgery
- Lung Surgery
- Cardiac Arrest
- Respiratory Failure

### **Heart Lung Machine Market Patient Age Outlook**

- Neonates
- Children
- Adults

### **Heart Lung Machine Market Flow Rate Outlook**

- Low Flow (less than 1 L/min)
- Medium Flow (1-2 L/min)
- High Flow (greater than 2 L/min)

### **Heart Lung Machine Market Number of Circuits Outlook**

- Single-Circuit Machines
- Dual-Circuit Machines
- Multi-Circuit Machines

### **Heart Lung Machine Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### Regulatory Support and Standardization

The Heart Lung Machine Market benefits from regulatory support and standardization initiatives that aim to enhance patient safety and product efficacy. Regulatory bodies are increasingly focusing on establishing stringent guidelines for the manufacturing and operation of heart lung machines. This regulatory framework not only ensures high-quality products but also fosters innovation within the industry. As manufacturers comply with these regulations, they are likely to gain a competitive edge, leading to increased market penetration. The anticipated growth in the market is further supported by the ongoing collaboration between regulatory agencies and industry stakeholders.

### Rising Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a significant driver for the Heart Lung Machine Market. Governments and private entities are channeling resources into upgrading medical facilities, particularly in emerging economies. This investment is aimed at enhancing surgical capabilities and improving patient care standards. As hospitals expand their cardiac care units, the demand for advanced heart lung machines is likely to rise. Reports indicate that healthcare expenditure is projected to increase by 5% annually, further propelling the market forward as facilities seek to adopt the latest technologies.

### Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases is a primary driver for the Heart Lung Machine Market. As populations age and lifestyle-related health issues become more common, the demand for cardiac surgeries is escalating. According to recent statistics, cardiovascular diseases account for nearly 31% of all global deaths, necessitating advanced surgical interventions. This trend is prompting healthcare facilities to invest in state-of-the-art heart lung machines to ensure optimal patient care. Consequently, the market is expected to witness substantial growth, with an increasing number of procedures requiring these machines.

### Growing Awareness and Education on Cardiac Health

The Heart Lung Machine Market is also influenced by the growing awareness and education surrounding cardiac health. Public health campaigns and educational programs are increasingly emphasizing the importance of early detection and treatment of cardiovascular diseases. This heightened awareness is leading to more individuals seeking medical attention, thereby increasing the number of surgical procedures performed. As healthcare providers respond to this demand, the need for reliable heart lung machines becomes paramount. The market is likely to expand as more patients are referred for surgical interventions, necessitating the use of these critical devices.

### Technological Advancements in Heart Lung Machines

The Heart Lung Machine Market is experiencing a surge in technological advancements that enhance the efficiency and safety of cardiac surgeries. Innovations such as miniaturization of components and integration of advanced monitoring systems are becoming prevalent. These developments not only improve patient outcomes but also reduce the risk of complications during procedures. For instance, the introduction of automated systems for blood management and oxygenation has shown to decrease the workload on surgical teams. As a result, the market is projected to grow at a compound annual growth rate of approximately 6.5% over the next five years, driven by these technological enhancements.

## Future Outlook

The Heart Lung Machine Market is projected to grow at a 4.49% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

**New opportunities:**

- Development of portable heart-lung machines for emergency medical services.
- Integration of AI for predictive maintenance and operational efficiency.
- Expansion into emerging markets with tailored financing solutions for hospitals.

By 2035, the Heart Lung Machine Market is expected to achieve robust growth, reflecting evolving healthcare needs.

## Segment Insights

### By Type: Cardiopulmonary Bypass Machines (Largest) vs. Extracorporeal Membrane Oxygenation (ECMO) Machines (Fastest-Growing)

The Heart Lung Machine Market is significantly influenced by its main segments: Cardiopulmonary Bypass Machines, ECMO Machines, and Assist Devices. Cardiopulmonary Bypass Machines hold the largest share due to their extensive application in complex cardiac surgeries, positioning them as the backbone of cardiac surgical procedures. In contrast, the ECMO Machines are emerging rapidly, capturing attention for their critical role in supporting patients with severe respiratory or cardiac failure, which has led to a notable increase in their adoption in recent years. Growth trends in the Heart Lung Machine Market reveal a shift towards innovative technologies and a rising demand for advanced critical care solutions. The market is driven by increasing incidences of cardiac and respiratory conditions, and a heightened awareness of the importance of timely interventions. Additionally, advancements in technology, such as miniaturization and enhanced monitoring capabilities, are propelling the development of new devices, particularly within the [ECMO](https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119)segment, making it the fastest-growing area of the market.

Cardiopulmonary Bypass Machines (Dominant) vs. Assist Devices (Emerging)

Cardiopulmonary Bypass Machines are the dominant force in the Heart Lung Machine Market, primarily due to their established role in performing heart surgeries, ensuring adequate blood flow and oxygenation during operations. They are known for their reliability and efficiency, crucial for life-sustaining applications. On the other hand, Assist Devices are gaining traction as emerging technologies, tailored for patients who require support but not full cardiopulmonary bypass. These devices, including ventricular assist devices, are designed for specific patient populations and represent the future of cardiac support, focusing on long-term management and improving patient quality of life.

### By Applications: Heart Surgery (Largest) vs. Lung Surgery (Fastest-Growing)

In the Heart Lung Machine Market, the applications are primarily categorized into Heart Surgery, Lung Surgery, Cardiac Arrest, and Respiratory Failure. Among these, Heart Surgery holds the largest market share due to the frequent use of heart-lung machines in various cardiac procedures. Additionally, segments like Lung Surgery and Cardiac Arrest are also significant contributors, but they lag behind the dominance of heart surgeries, which are a staple in cardiac care, especially with the rising prevalence of heart diseases.

Heart Surgery: Dominant vs. Lung Surgery: Emerging

Heart Surgery remains the dominant application in the Heart Lung Machine Market, primarily due to the high demand for these machines during complex cardiac procedures, including open-heart surgery and valve replacements. The preference for technologically advanced heart-lung machines that ensure patient safety and efficiency in surgeries has fortified this segment's position. On the other hand, Lung Surgery is emerging rapidly, fueled by innovations in minimally invasive techniques that enhance recovery and outcomes. As respiratory issues, including chronic obstructive pulmonary disease (COPD), become more prevalent, the use of heart-lung machines in lung surgeries is expected to increase, driving its growth in the market.

### By Patient Age: Adults (Largest) vs. Neonates (Fastest-Growing)

The Heart Lung Machine Market exhibits a diverse distribution among different patient age segments, with adults representing the largest share. This demographic's substantial proportion is driven by the prevalence of heart and lung surgeries required in middle-aged and older populations. In contrast, the neonate segment, while smaller, shows remarkable growth potential. Advances in technology and increased surgical interventions for congenital heart defects contribute to the rising share of neonates within the market.

Adults (Dominant) vs. Neonates (Emerging)

The adult segment in the Heart Lung Machine Market is characterized by its dominance, attributing to a larger patient population undergoing complex cardiac and thoracic surgeries. Adult patients require sophisticated, reliable heart lung machines for lengthy procedures, leading to greater demand from healthcare facilities. Conversely, the neonate segment is emerging rapidly, facilitated by technological advancements in pediatric cardiology. Neonates are increasingly receiving life-saving surgical procedures for congenital conditions, reflecting a significant shift in healthcare focus and driving innovation in machine design tailored for infants, ensuring their safety and efficacy.

### By Flow Rate: High Flow (Largest) vs. Medium Flow (Fastest-Growing)

In the Heart Lung Machine Market, the distribution of flow rate segments showcases a diverse competitive landscape. High Flow systems, defined as those exceeding 2 L/min, hold the largest share, attributed to their preference in complex surgeries requiring robust support. Medium Flow systems, operating between 1-2 L/min, are also significant but are gaining traction among clinicians seeking versatility and effectiveness in various procedures. Conversely, Low Flow systems, under 1 L/min, occupy a smaller niche but are indispensable in specific scenarios, especially in minimally invasive surgeries. Growth trends within this segment are fueled by technological advancements and increasing adoption rates in hospitals. High Flow systems are witnessing sustained demand due to their reliability and effectiveness in surgeries with higher patient complexity. The shift towards minimally invasive techniques is propelling Medium Flow systems as healthcare providers prioritize efficiency and patient recovery. As a result, the market anticipates a notable rise in the adoption of these systems, positioning medium flow as the fastest-growing segment in the near future.

High Flow (Dominant) vs. Medium Flow (Emerging)

High Flow systems in the Heart Lung Machine Market cater to a significant demand for comprehensive support during complex surgical procedures, making them the dominant force in this segment. Their ability to deliver high volumes of blood with precision provides robust support for patients with severe cardiac conditions. Medium Flow systems are emerging as essential tools due to their adaptability in various surgical contexts. While they do not match High Flow systems in sheer volume, their efficiency and lower invasiveness make them increasingly attractive. This duality allows healthcare professionals to select systems based on specific surgical needs, driving innovation and competition in an evolving market.

### By Number of Circuits: Dual-Circuit Machines (Largest) vs. Single-Circuit Machines (Fastest-Growing)

The Heart Lung Machine Market is characterized by a diverse distribution of circuits used in surgical applications. Dual-Circuit Machines hold the largest share, preferred for their ability to manage complex procedures more effectively. In contrast, Single-Circuit Machines are gaining traction due to their simplicity, ease of use, and significant growth, appealing to niche markets that prioritize efficiency over flexibility. The growth trends within this segment are largely influenced by advancements in technology and increasing surgical procedures worldwide. The demand for more sophisticated and versatile machines is driving the adoption of Dual-Circuit Machines, while Single-Circuit Machines are becoming popular in outpatient and less complex surgeries. The technological enhancements and effective patient management capabilities are key to their expanding utilization in the healthcare sector.

Dual-Circuit Machines (Dominant) vs. Single-Circuit Machines (Emerging)

Dual-Circuit Machines dominate the market due to their superior performance in complex cardiovascular surgeries, offering improved oxygenation and hemodynamic stability. These machines are equipped with advanced features that facilitate longer procedures, making them essential for high-risk patients. In contrast, Single-Circuit Machines, while emerging, are designed for efficiency and ease of handling, catering to less complex and routine surgeries. Their compact design and cost-effectiveness are appealing to healthcare facilities seeking to optimize operational costs. As the healthcare field evolves, both machine types are expanding their use, fueled by rising surgical volume and progressive technological innovations.

## Regional Market Share Analysis

The Heart Lung Machine Market is segmented into North America, Europe, APAC, South America, and MEA. The North American region is expected to hold the largest market share, followed by Europe and APAC. The growth in the North American region is attributed to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive surgeries. The European market is expected to grow at a steady pace, driven by the increasing adoption of advanced technologies and the growing number of cardiac surgeries.

The APAC region is expected to witness the fastest growth, owing to the rising healthcare expenditure and the increasing awareness about heart-lung machines.The South American and MEA regions are expected to grow at a moderate pace, driven by the increasing number of hospitals and the growing demand for cardiac care. North America 3.378 - 4.753 USD Billion, Europe 2.099 - 3.176 USD Billion, South America 0.651 - 0.98 USD Billion, Asia-Pacific 1.953 - 3.059 USD Billion, Middle East and Africa 0.398 - 0.612 USD Billion.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## Competitive Benchmarking

Major players in the Heart Lung Machine Market are constantly competing to gain an edge in the industry. Leading Heart Lung Machine Market players are focusing on developing innovative products and technologies, expanding their reach, and strengthening their distribution channels. Key players are adopting various strategies, such as mergers and acquisitions, joint ventures, and strategic partnerships, to enhance their market position.
In addition, new entrants and emerging markets are challenging the existing competitive landscape and driving Heart Lung Machine Market development.Stryker Corporation is a leading player in the Heart Lung Machine Market and offers a wide range of advanced products and solutions. The company is renowned for its commitment to innovation and customer satisfaction. With a strong presence and a comprehensive distribution network, Stryker Corporation effectively serves healthcare facilities worldwide.
Its continuous focus on product development, strategic acquisitions, and long-standing customer relationships contribute to its leading position in the Heart Lung Machine Market industry.Medtronic, a prominent competitor in the Heart Lung Machine Market, is recognized for its innovative technologies and comprehensive product portfolio.
The company holds a strong position in the market and has established a robust presence in key regions. Medtronic emphasizes research and development, investing in advanced technologies and solutions to meet the evolving needs of healthcare professionals and patients. Through its strong brand reputation, distribution network, and strategic partnerships, Medtronic remains a formidable competitor in the Heart Lung Machine Market Competitive Landscape.

## Recent News & Developments

The heart-lung machine market is projected to grow from an estimated USD 8.48 billion in 2024 to USD 12.58 billion by 2032, at a CAGR of 4.49%. This growth is attributed to the increasing prevalence of cardiovascular diseases, the rising demand for minimally invasive surgeries, and technological advancements in heart-lung machines.Key recent developments in the market include In 2023, Medtronic received FDA approval for its HeartWare HVAD System, the first implantable heart pump designed for patients with advanced heart failure who are not eligible for heart transplantation.

 In 2024, Abbott launched the CentriMag Blood Pump System, a next-generation heart-lung machine that offers improved patient outcomes and reduced complications. In 2025, Terumo Cardiovascular Group announced the acquisition of Vascutek, a leading provider of cardiovascular devices, including heart-lung machines.These developments indicate a growing focus on innovation and patient-centric solutions in the heart-lung machine market.

## Report Scope

| MARKET SIZE 2024 | 8.861(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 9.259(USD Billion) |
| MARKET SIZE 2035 | 14.36(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.49% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Terumo Corporation (JP), Getinge AB (SE), LivaNova PLC (GB), Abbott Laboratories (US), Cardinal Health (US), Sorin Group (IT), Nipro Corporation (JP), Fresenius SE & Co. KGaA (DE) |
| Segments Covered | Product Type, Applicationss, Patient Age, Flow Rate, Number of Circuits, Regional |
| Key Market Opportunities | Integration of advanced monitoring systems enhances patient safety in the Heart Lung Machine Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Heart Lung Machine market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Heart Lung Machine Market by 2035?**
A: The Heart Lung Machine Market is projected to reach a valuation of 14.36 USD Billion by 2035.

**Q: What was the market valuation of the Heart Lung Machine Market in 2024?**
A: In 2024, the Heart Lung Machine Market was valued at 8.861 USD Billion.

**Q: What is the expected CAGR for the Heart Lung Machine Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Heart Lung Machine Market during the forecast period 2025 - 2035 is 4.49%.

**Q: Which segment of the Heart Lung Machine Market had the highest valuation in 2024?**
A: In 2024, the Cardiopulmonary Bypass Machines segment had the highest valuation at 3.5 USD Billion.

**Q: What are the projected valuations for the Assist Devices segment by 2035?**
A: The Assist Devices segment is projected to reach a valuation of 4.86 USD Billion by 2035.

**Q: Which patient age group is expected to contribute the most to the Heart Lung Machine Market by 2035?**
A: By 2035, the Adult patient age group is expected to contribute the most, with a projected valuation of 7.86 USD Billion.

**Q: What is the anticipated market performance for Extracorporeal Membrane Oxygenation (ECMO) Machines by 2035?**
A: The Extracorporeal Membrane Oxygenation (ECMO) Machines segment is anticipated to reach a valuation of 4.0 USD Billion by 2035.

**Q: How do the valuations of Low Flow and High Flow segments compare in 2024?**
A: In 2024, the Low Flow segment was valued at 1.5 USD Billion, whereas the High Flow segment was valued at 3.861 USD Billion.

**Q: Which key players are leading the Heart Lung Machine Market?**
A: Key players in the Heart Lung Machine Market include Medtronic, Terumo Corporation, and Getinge AB, among others.

**Q: What is the projected valuation for Dual-Circuit Machines by 2035?**
A: The Dual-Circuit Machines segment is projected to reach a valuation of 5.5 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/heart-lung-machine-market-41089*